Showing results (31-40 of 76) with videos related to
Sort By:
Pageof 8
Mass Spectrometry Reviews|November 12, 2024
Mass Spectrometry Advances in Analysis of GlioblastomaSofian Al Shboul, Ashita Singh, Renata Kobetic, et al.Proteomics|June 9, 2016
Rearrangement of mitochondrial pyruvate dehydrogenase subunit dihydrolipoamide dehydrogenase protein-protein interactions by the MDM2 ligand nutlin-3Luke Way, Jakub Faktor, Petra Dvorakova, et al.Molecular Biology and Evolution|July 6, 2022
The Elephant Evolved p53 Isoforms that Escape MDM2-Mediated Repression and CancerMonikaben Padariya, Mia-Lyn Jooste, Ted Hupp, et al.Bioorganic & Medicinal Chemistry|July 16, 2022
Comparison of ATP-binding pockets and discovery of homologous recombination inhibitorsVincent Blay, Saule Gailiunaite, Chih-Ying Lee, et al.Journal of Proteome Research|September 23, 2011
Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistanceShawna Mae Hengel, Euan Murray, Simon Langdon, et al.Proteomics|October 21, 2025
Proteomic Changes in Cancer Cell Lines as a Result of Bacterial InfectionBo Ren, Kenneth Weke, Darryl Hardie, et al.Antibody Therapeutics|May 3, 2021
A blocking antibody against canine CSF-1R maturated by limited CDR mutagenesisBreno C B Beirão, Teresa P Raposo, Louise M Imamura, et al.Antiviral Research|June 28, 2024
Molecules targeting a novel homotrimer cavity of Spike protein attenuate replication of SARS-CoV-2Alison Daniels, Monikaben Padariya, Sarah Fletcher, et al.The Journal of Biological Chemistry|January 25, 2007
A germ line mutation in the death domain of DAPK-1 inactivates ERK-induced apoptosisCraig Stevens, Yao Lin, Maria Sanchez, et al.SLAS Discovery : Advancing Life Sciences R & D|May 23, 2020
High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug DiscoveryRebecca E Hughes, Richard J R Elliott, Alison F Munro, et al.Pageof 8